SCHEMBL4184975

SCHEMBL4184975

O=C(O)c1ccc2c(c1)CCC2NCCc1c[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CDK4 P11802 2/20 0.49
CCND1 P24385 2/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MTNR1A P48039 2/20 0.48
CDK2 P24941 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
HTR1A P08908 2/20 0.48
FAAH O00519 1/20 0.47
HTR1B P28222 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4180696 0.87 MEN1 (0.48) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL13653089 0.87 MEN1 (0.47) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL4197650 0.86 MEN1 (0.46) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4178795 0.85 HDAC1 (0.55) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL5741250 0.84 MEN1 (0.50) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL5741253 0.84 MEN1 (0.50) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL5744501 0.83 MEN1 (0.49) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL5744492 0.83 MEN1 (0.49) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL27632003 0.82 MEN1 (0.51) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL22516782 0.81 MEN1 (0.49) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed
EP-1802577-A1 INDANE AMIDES WITH ANTIPROLIFERATIVE ACTIVITY Bayer Pharmaceuticals Corporation (US) 2007-07-04 EP disclosed
WO-2006062580-A1 INDANE AMIDES WITH ANTIPROLIFERATIVE ACTIVITY BAYER PHARMACEUTICALS CORPORATION (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 MEN1 612/4885KMT2A 1662/4885ALDH1A1 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.